Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immucell (ICCC) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Immucell (ICCC) over the last 15 years, with Q3 2025 value amounting to 0.06%.

  • Immucell's Return on Capital Employed rose 1100.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 0.04% for FY2024, which is 1000.0% up from last year.
  • Per Immucell's latest filing, its Return on Capital Employed stood at 0.06% for Q3 2025, which was up 1100.0% from 0.04% recorded in Q2 2025.
  • Over the past 5 years, Immucell's Return on Capital Employed peaked at 0.06% during Q3 2025, and registered a low of 0.16% during Q3 2023.
  • Over the past 5 years, Immucell's median Return on Capital Employed value was 0.04% (recorded in 2024), while the average stood at 0.04%.
  • In the last 5 years, Immucell's Return on Capital Employed plummeted by -1600bps in 2023 and then surged by 1200bps in 2025.
  • Quarter analysis of 5 years shows Immucell's Return on Capital Employed stood at 0.01% in 2021, then crashed by -978bps to 0.05% in 2022, then plummeted by -120bps to 0.12% in 2023, then surged by 66bps to 0.04% in 2024, then surged by 236bps to 0.06% in 2025.
  • Its Return on Capital Employed was 0.06% in Q3 2025, compared to 0.04% in Q2 2025 and 0.01% in Q1 2025.